Drugs / CIR-0602K
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07186660 Comparator | Feb 2026 → Sep 2028 expected | type 1 diabetes mellitus | University of Virginia | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CIR-0602K | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07186660 ↗ |
| Action | Inhibit | “mitochondrial pyruvate carrier inhibitor” NCT07186660 ↗ |